本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

22.18
+0.94004.43%
成交量:23.57萬
成交額:510.73萬
市值:25.13億
市盈率:-6.41
高:22.18
開:21.47
低:21.27
收:21.24
52周最高:34.29
52周最低:13.18
股本:1.13億
流通股本:1.01億
量比:0.87
換手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):-3.4579
每股收益(LYR):-3.3245
淨資產收益率:-65.74%
總資產收益率:-30.16%
市淨率:4.45
市盈率(LYR):-6.67

資料載入中...

2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/06

重要事件披露

8-K - Current report
2023/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/19

重要事件披露

8-K - Current report
2022/08/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/16

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/08/16

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/08/16

重要事件披露

8-K - Current report
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/23

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]